Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetonitrile. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetonitrile SCHEMBL5101803 | 1.00 | — | — | |
| Acetonitrile SCHEMBL27613489 | 0.96 | ALDH1A1 (0.46) | — | |
| Acetonitrile SCHEMBL2255717 | 0.96 | — | — | |
| Acetonitrile SCHEMBL195728 | 0.96 | — | — | |
| Acetonitrile SCHEMBL1037904 | 0.96 | ALDH1A1 (0.55) | — | |
| Acetonitrile SCHEMBL27696068 | 0.96 | — | — | |
| Acetonitrile SCHEMBL7327719 | 0.96 | ALDH1A1 (0.55) | — | |
| Acetonitrile SCHEMBL9188145 | 0.96 | ALDH1A1 (0.55) | — | |
| Acetonitrile SCHEMBL4864430 | 0.92 | — | — | |
| Acetonitrile SCHEMBL9044559 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107202849-B | Method for separating and determining vitamin E and impurities in preparation of vitamin E by HPLC (high performance liquid chromatography) | 济南维瑞医药科技开发有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-117783396-A | Method for detecting other sterols in cholesterol and application of method | 广州白云山汉方现代药业有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-116482241-A | Liquid chromatography-mass spectrometry combined method and kit for detecting metabolites of vitamin D | 广州凯普医药科技有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-113092618-B | Method for detecting related substances in 13 compound vitamins for injection | 广州汉光药业股份有限公司 | 2022-09-20 | — | — | CN | disclosed |
| US-20220213099-A1 | PRODRUG COMPOUNDS | BRISTOL MYERS SQUIBB CO (US) | 2022-07-07 | — | — | US | disclosed |
| CN-113092618-A | Method for detecting related substances in 13 compound vitamins for injection | 广州汉光药业股份有限公司 | 2021-07-09 | — | — | CN | disclosed |
| CN-107202849-B | Method for separating and determining vitamin E and impurities in preparation of vitamin E by HPLC (high performance liquid chromatography) | 济南维瑞医药科技开发有限公司 | 2021-03-30 | — | — | CN | disclosed |
| WO-2020227337-A1 | PRODRUG COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-11-12 | — | — | WO | disclosed |
| US-9625359-B2 | Tissue sample preparation, and MALDI MS imaging thereof | BRANDEIS UNIVERSITY (US) | 2017-04-18 | — | — | US | disclosed |
| US-20150300930-A1 | Tissue Sample Preparation, and MALDI MS Imaging Thereof | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2015-10-22 | — | — | US | disclosed |
| US-8894993-B2 | Mitochondria-targeted antioxidants | NATREON INC. (US) | 2014-11-25 | — | — | US | disclosed |
| CN-103288801-A | Preparation method for high-purity esomeprazole sodium | SICHUAN BIOKIN PHARMACEUTICAL CO LTD | 2013-09-11 | — | — | CN | disclosed |
| EP-2049136-A1 | MITOCHONDRIA-TARGETED ANTIOXIDANTS | Natreon Inc. (US) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008016554-A1 | MITOCHONDRIA-TARGETED ANTIOXIDANTS | NATREON, INC. (US) | 2008-02-07 | — | — | WO | disclosed |
| US-20080031862-A1 | Mitochondria-targeted antioxidants | NATREON, INC. | 2008-02-07 | — | — | US | disclosed |
| US-7241775-B2 | Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-07-10 | — | — | US | disclosed |
| US-20050009863-A1 | Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2005-01-13 | — | — | US | disclosed |
| WO-2000067009-A1 | MIXED BUFFERS IN GEL ELECTROPHORESIS SYSTEMS | APPLIED HYDROGEL TECHNOLOGY CORPORATION (US) | 2000-11-09 | — | — | WO | disclosed |